Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells. (Q40461869)

20 September 2017

title

Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells. (English)

1 reference

20 September 2017

Carsten Finger

1

1 reference

20 September 2017

Yuansheng Sun

2

1 reference

20 September 2017

Laura Sanz

3

1 reference

20 September 2017

Luis Alvarez-Vallina

4

1 reference

20 September 2017

Christian J Buchholz

5

1 reference

20 September 2017

Klaus Cichutek

6

1 reference

20 September 2017

publication date

1 May 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

12

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

464-474

1 reference

Gene therapy for cancer: what have we done and where are we going?

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Cancer gene therapy: hard lessons and new courses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Replicating vectors for gene therapy of cancer: risks, limitations and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Selectively replicating adenoviruses for oncolytic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Strategies for achieving multiple layers of selectivity in gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

21 January 2018

Viral vector targeting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Gene therapy for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Replication-competent Moloney murine leukemia virus carrying a bacterial suppressor tRNA gene: selective cloning of proviral and flanking host sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

In vivo selection of protease cleavage sites from retrovirus display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Generation and characterization of recombinant human antibodies specific for native laminin epitopes: potential application in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Targeting human T cells by retroviral vectors displaying antibody domains selected from a phage display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Expression of novel 400-kDa laminin chains by mouse and bovine endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Laminin isoforms and epithelial development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Expression of heterologous genes from an IRES translational cassette in replication competent murine leukemia virus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Processing of a fusion protein by endoprotease in COS-1 cells for secretion of mature peptide by using a chimeric expression vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Clinical research. Gene therapy a suspect in leukemia-like disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

Tissue-specific transcriptional targeting of a replication-competent retroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

7 January 2021

Construction of a replication-competent murine retrovirus vector expressing the human immunodeficiency virus type 1 tat transactivator protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

7 January 2021

Optimization of retroviral gene transduction of mobilized primitive hematopoietic progenitors by using thrombopoietin, Flt3, and Kit ligands and RetroNectin culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

7 January 2021

Endothelial cell-specific transcriptional targeting from a hybrid long terminal repeat retrovirus vector containing human prepro-endothelin-1 promoter sequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700805

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700805

1 reference

Dimensions Publication ID

20 September 2017

1022181138

0 references

1 reference